Biosimilar interchangeability designation, which allows automatic pharmacy-level substitution, carrying its own regulatory evidentiary requirements that most biosimilars have not cleared on launch day
Bielinski SJ, Yanes Cardozo LL, Takahashi PY, Larson NB, Castillo A, Podwika A, De Filippis E, Hernandez V, Mahajan GJ, Gonzalez C, Shubhangi, Decker PA, Killian JM, Olson JE, St Sauver JL, Shah P, Vella A, Ryu E, Liu H, Marshall GD, Cerhan JR, Singh D, Summers RL
The IV (intravenous) method of administration allows much higher doses of glutathione to enter the cells than would otherwise be possible by dietary modification or oral supplements
The increase in use of these drugs, though, can seem alarming
It is based on current scientific literature and research trends